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ABSTRACT
Polyaromatic hydrocarbons (PAHs) are ubiquitously present in the environment and
have deleterious affects on humans. Cytochrome P450 enzymes have been found to be
useful in the biodegradation of the PAHs through an initial hydroxylation step. This
makes them more water-soluble and accessible to the action of other oxidases.
Cytochrome P450cam is a model P450 enzyme that has been mutated for enabling PAH
and alkane hydroxylation. P450s therefore have potential for use in commercial process
for production of primary alcohols.
Rhodococcus organisms have a special mechanism for transporting the hydrophobic
hydrocarbons into their cells. Cloning of the P450cam gene into Rhodococcus can potentially
provide a hydroxylation system with high conversion rates. To enable this, cytochrome
P450cam gene (CYP101) was cloned into a Rhodococcus-Escherichia coli shuttle vector. This
would provide tools to modify the gene and target specific PAHs. This study is aimed at
developing a Rhodococcus-based biocatalyst using cytochrome P450 enzymes.
The cytochrome P450cam gene was synthesized using PCR (polymerase chain reaction);
the product was cloned into pKSD6-1 (a Rhodococcus-Escherichia coli shuttle vector) and
transformed into Escherichia coli. The recombinant protein in Escherichia coli was produced
by induction and the protein extract was analyzed using spectrophotometric analysis,
camphor binding and carbon monoxide binding assays.
The results showed a Soret band at 414nm but no carbon monoxide or substrate binding
was observed. The control culture grown under similar conditions with only the pKSD6vi

1 gene did not show any absorption band at 414nm. These results together indicate that
the gene has been cloned into the recombinant plasmid, but the enzyme being produced
might be in an inactive form.

vii

TABLE OF CONTENTS
INTRODUCTION .........................................................................................................1
1.1 Background.............................................................................................................1
1.2 Overview .................................................................................................................7
LITERATURE REVIEW ...........................................................................................11
2.1 Cytochrome P450 ................................................................................................11
2.3 Shuttle vectors ......................................................................................................40
2.4 pCWori plasmid ...................................................................................................45
METHODS AND RESULTS....................................................................................47
3.1 Introduction..........................................................................................................47
3.2 Production of the gene from pCWori plasmid containing CYP101 using PCR 47
3.3 Attempt to directly clone cytochrome P450cam into pKSD6-1 ...................52
3.4 Cloning of cytochrome P450cam into pCR 2.1 TOPO..................................54
3.5 Cloning of cytochrome P450 from 3-TOPO+CYP101 to pKSD6-1.......61
3.6 Ligation of the insert into the vector ...............................................................63
3.6 Production of the P450cam enzyme ...................................................................66
3.7 Spectral analysis of P450cam after Carbon monoxide binding......................69
3. 8 Assay using the camphor bound cytochrome P450cam ................................72
3.9 Control experiment .............................................................................................73
3.10 Analysis of Recombinant DNA......................................................................75
ANALYSIS AND DISCUSSION..............................................................................79
4.1 Recombinant Protein Expression in Escherichia coli .......................................79
4.2 Requirements for expression of cytochrome P450cam in Escherichia coli .....81
4.3 Synthesis of cytochrome P450cam enzyme in Escherichia coli using the vector
pKSD6-1......................................................................................................................82
4.4 The chloramphenicol resistance gene ..............................................................86
4.5 Spectral Analysis of the P450cam enzyme from the recombinant plasmid.87
4.6 Possibility of the enzyme being cytochrome P420........................................89
4.7 Other Possible reasons for the lack of enzymatic activity ...........................90
SUMMARY AND FUTURE WORK ......................................................................91
5.1 Summary................................................................................................................91
5.2 Future work...........................................................................................................93
BIBLIOGRAPHY..........................................................................................................95
VITA ................................................................................................................................ 104

viii

LIST OF FIGURES

Figure 1: Structure of porphyrin...............................................................................................................4
Figure 2: Structure of Pyrrole Ring ..........................................................................................................4
Figure 3: Structure of Heme......................................................................................................................5
Figure 4: Various classes of P450 systems. [7] .................................................................................... 13
Figure 5: Electron transfer systems in CYP101 and CYP11A1 [10] .............................................. 16
Figure 6: 3D structures of Adx (top) and Pdx (bottom). [10].......................................................... 17
Figure 7: Catalytic cycle of Pseudomonas putida P450cam [17]............................................................... 23
Figure 8: Electron Transport from PdR to P450cam Mediated by Pdx. [20] .................................. 25
Figure 9: Possible mechanisms for transfer of electrons from PdR to P450cam The oval
represents the porphyrin ring of camphor-bound P450cam [20] ........................................ 27
Figure 10: Catalytic cycle of cytochrome P450, showing the individual steps at which
uncoupling can occur. [21] ....................................................................................................... 29
Figure 11: Active site of the P450cam enzyme with camphor bound in it [24] ........................... 33
Figure 12: Restriction maps of pKG3OO and its derivatives. [3]................................................... 36
Figure 13: Sequencing strategy of the cytochrome P-450 gene.[3] ................................................. 37
Figure 14: The complete nucleotide sequence of the cytochrome P-450 gene and a 5'
portion of the putidaredoxin reductase gene. [3] ................................................................. 39
Figure 15: Construction of the deletion derivatives of the pSOX plasmid. [18].......................... 44
Figure 16: Construction of the pKSD 6-1 Rhodococcus-Escherichia coli shuttle vector. [18] ........... 45
Figure 17: pCWori+P450cam ................................................................................................................... 48
Figure 18:Gel showing the 1.4 kbp P450 gene from the PCR optimization buffers. ................. 51
Figure 19: Gel analysis of the insert and vector restricted with ApaI and SacI............................ 53
Figure 20: Gel showing the restriction of pKSD6-1 w/ SacI (3) and Apa I (5)........................... 53
Figure 21: Gel analysis of pKSD6-1 restricted with various enzymes. .......................................... 54
Figure 22: Gel showing the CYP101 and the control genes ............................................................ 56
Figure 23: pCR2.1 TOPO+CYP101 plasmid ..................................................................................... 57
Figure 24: pCR 2.1 TOPO+CYP101 with NotI restriction ............................................................ 58
Figure 25: Gels showing the 3.8kbp band instead of the expected 5.4kbp in the DNA
isolated from twenty different colonies. ................................................................................ 59
Figure 26: Gel showing the presence of the 5.4 kbp linear TOPO+CYP101 plasmid............... 60
Figure 27: Gel showing 3- TOPO+P450 w/ NotI and EcoRV ..................................................... 62
Figure 28: 3-TOPO+CYP101 plasmid showing ApaI sites flanking the cytochrome
P450cam gene. ............................................................................................................................... 62
Figure 29: 3-TOPO+CYP101 with /ApaI restriction ...................................................................... 64
Figure 30: Gel with insert and vector DNA........................................................................................ 64
Figure 31: Absorbance spectra of the oxidized P450cam .................................................................... 70
Figure 32: Absorbance spectra of the concentrated P450cam............................................................ 70
ix

Figure 33: Absorption spectra on adding dithionite (shift from 414nm to 411nm).................... 72
Figure 34: Absorption spectra of the Oxidized P450cam containing 5mM camphor ................... 73
Figure 35: Absorbance spectra of oxidized P450cam and camphor with dithionite...................... 74
Figure 36: Absorbance spectra of P450cam+ Camphor+ Dithionite +Carbon monoxide ......... 74
Figure 37: Absorption spectra of the protein extract control and recombinant culture............. 76
Figure 38: Difference in spectra of control (concentrated) and recombinant protein
extract ........................................................................................................................................... 76
Figure 39: Agarose gel showing the uncut recombinant pKSD6-1+P450 at 20kbp................... 77
Figure 40: Restriction digests of recombinant pKSD6-1+P450 with various enzymes. ............ 78
Figure 41: Schematic presentation of the salient features and sequence elements of a
prokaryotic expression vector. [38]......................................................................................... 80
Figure 42: Sequence of a part of pKSD6-1 containing the CYP101 gene in its MCS ................ 84
Figure 43: The direction of translation of the protein....................................................................... 85
Figure 44: 415 aa sequence encoded by the gene............................................................................... 86

x

Chapter 1

INTRODUCTION
1.1 Background
Proteins are the molecular instruments through which the genetic information
is expressed. They are the most abundant biomolecules and are diverse in
their functions. Enzymes are highly specialized proteins and are central to
every biochemical process; they serve as reaction catalysts of the biological
systems. Enzymes are more desirable than their chemical catalysts because of
their superior catalytic power, high degree of specificity for their substrates
and their ability to function in aqueous solutions under mild conditions of
temperature and pressure. These properties of the enzymes have led to
important applications in the fields of medicine, chemical industry, food
processing and agriculture. [1]
Oxygenases are enzymes that catalyze oxidative reactions in which the oxygen
atoms are directly incorporated into the substrate molecule forming a new
hydroxyl or a carboxyl group. Among these are dioxygenases, which catalyze
reactions in which both the oxygen atoms are incorporated into the organic
substrate molecule and monooxygenases, that are more abundant in nature,
catalyze reactions in which only one of the oxygen atoms is incorporated into the
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substrate while the other is reduced to water. The main substrate accepts one of
the oxygen atoms and the co-substrate furnishes the Hydrogen atom to reduce
the other oxygen atom. The general reaction catalyzed by the monooxygenases is
AH + BH 2 + O − O 
→ A − OH + B + H 2 O

(1)

In the above equation AH is the main substrate and BH2 is the co-substrate.
Monooxygenases are also known as hydroxylases as they catalyze reactions in
which the main substrate becomes hydroxylated. They are also known as mixed
function oxidases or mixed-function oxygenases to indicate that they oxidize two
different

substrates

simultaneously.

The

co-substrate

used

by

the

monooxygenases is a reduced flavin nucleotide such as FADH2 or FMNH2, some
enzymes use NADH or NADPH while a very few use α-ketoglutarate. [1]
A type of heme protein called cytochrome P450 (CYP) catalyzes a vast number
of very complex monooxygenation reactions. It is capable of catalyzing the
oxidation of the C-H bonds to alcohol functionality. The P450 enzymes have the
ability to selectively oxidize an array of endogenous and exogenous organic
compounds ranging from medium chain alkanes such as n-heptane and n-octane
to steroidal, polyaromatic and very large molecules such as triterpenes without
further oxidation to aldehydes and ketones. This is therefore a novel alternative
to the industry where all current alkane oxidation processes use elevated
temperatures and pressures and metal oxide catalysts, which do not have the
required activity, selectivity or specificity. [2]
2

All heme proteins consist of a porphyrin ring, which binds the iron atom.
Porphyrins are planar ligands with a central ring structure and various substituent
groups at the edges of the ring as shown in Figure 1. The central ring structure of
the porphyrins consists of four pyrrole rings and the structure of a pyrrole ring is
shown in Figure 2. Heme is a metalloporphyrin with the complex organic ring
structure of a protoporphyrin with the iron atom bound in its ferrous (Fe2+) state.
Metalloporphyrins, contain a metal atom bound to a porphyrin and are
synthesized naturally and utilized biologically as redox catalysts. These
metalloporphyrins possess characteristic absorption spectra that can be used for
identification and quantitative estimation of the porphyrins and porphyrin bound
compounds. These metal complexes are incorporated into many proteins as
prosthetic groups. Within the protein framework the prosthetic group is a
versatile tool with highly specialized functions.
Heme serves as a prosthetic group among various classes of proteins such as the
globins, catalases, hydrogen-binding peroxidases, cytochrome P450 etc. As seen
in the Figure 3 the iron atom of the heme has six coordination bonds, four to the
nitrogen atoms of the porphyrin ring system and two, perpendicular to the plane
of the porphyrin .The unique C-H activation activity of cytochrome P450 has no
equivalent in classical synthetic methodologies.
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Figure 1: Structure of porphyrin

Figure 2: Structure of Pyrrole Ring
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Figure 3: Structure of Heme
The electron-donating nitrogen atoms to which the iron atom is bound in the
heme prevent the oxidation of the iron to ferric state thereby preserving its
reversible oxygen binding capacity. This is one of the reasons why the heme
group is embedded deep inside the proteins that contain it. They also generally
have a His (Histidine) residue occupying one of the coordinate bonds leaving
only one site for the oxygen to bind. Small molecules such as carbon monoxide
(CO) and Nitric oxide (NO) coordinate to the heme iron with an affinity greater
than that of oxygen. [1]
Among the cytochrome P450 enzymes, cytochrome P450cam was the first P450
enzyme to be structurally characterized and has been studied in detail.
Cytochrome P450cam from the soil bacterium Pseudomonas putida is responsible for
5

the stereo specific methylene hydroxylation of camphor as the first step in the
compound’s catabolism when used as the sole carbon source. Cytochrome
P450cam is a soluble enzyme that is obtainable in relatively large amounts with a
high purity. It has been used extensively as a model to investigate the chemical
and biophysical mechanisms of P-450 dependent mechanisms. [2]
It has been shown that cytochrome P450cam can be engineered to oxidize many
different classes of compounds that are structurally unrelated to its natural
substrate camphor. Increasing the hydrophobicity of the active site in P450cam by
random mutagenesis is shown to increase its activity towards hydrophobic
molecules that are both smaller than camphor like simple alkanes and larger ones
such as naphthalene and pyrene. [3]

Polycyclic aromatic hydrocarbons (PAHs) are hazardous and are persistent in the
environment. They are procarcinogens and their carcinogenicity is expressed by
their oxidation by the human cytochrome P450 enzymes such as CYP1A1. The
inability of the PAHs to be soluble in water and the lack of naturally occurring
microbial enzyme systems for their efficient degradation are the reasons for their
persistence in the environment. Initial oxidation by the P450 monooxygenases
and non-heme dependent dioxygenases has been reported to be the probable
rate-limiting step after the microorganism sequesters the PAHs. All the P450
enzymes follow the same mechanism of generating the ferryl intermediate
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species, which attacks a variety of substrates. This combined with the fact that
P450 enzymes are involved in the PAH carcinogenesis of the mammals and the
PAH bioremediation by the microorganisms provides reason enough to
investigate methods which will enable the use of these enzymes to degrade the
PAHs. [3]
1.2 Overview
This section introduces objective, concept and experimental philosophy of the
cloning of the cytochrome P450cam gene into the Rhodococcus-Escherichia coli shuttle
vector pKSD6-1 (obtained from Peter C.K. Lau and Matthew J. Grossman,
Biotechnology Research Institute, National Research Council, Quebec, Canada).
The basic idea behind cloning cytochrome P450cam into a Rhodococcus-Escherichia coli
shuttle vector is to produce the camphor-binding enzyme in the new host
Rhodococcus and modify the enzyme genetically using random mutagenesis so that
the enzyme will be able to act on polycyclic aromatic hydrocarbons and in the
production of primary alcohols. This involved firstly cloning the recombinant
pKSD6-1 +CYP101 plasmid into Escherichia coli and then transforming it into
Rhodococcus.
The hydrocarbon-degrading enzymes are a part of the cytoplasmic membrane
system, so the hydrocarbon substrate has to be transported through the
hydrophilic cell wall into the cell to be metabolized. This step of hydrocarbon
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intake is strongly limited by the hydrophobic character of these substrates.
Rhodococcus is one of the organisms that are able to utilize hydrocarbons; it is able
to do so by changing the physical-chemical character of its cell wall by inserting
amphiphilic molecules into its surface layers thereby assuring the efficient
transport by a strong cell attachment to the hydrophobic substrate. [4]
Rhodococcus organism therefore has an extraordinary capacity for metabolizing
recalcitrant organic compounds and has a demonstrated solvent tolerance, which
make it a suitable host for cloning CYP101. The full exploitation of Rhodococcus is
limited by the lack of genetic tools for manipulating the organism. The lack of
such knowledge in Rhodoccocus is compensated by the extensive knowledge on the
genetics and the molecular biology of Escherichia coli, which provide all the
necessary tools to facilitate its use while performing random mutagenesis to
create a biocatalyst, which can act on substrates other than camphor. [5]
Cloning of the cytochrome P450cam gene into the Rhodococcus-Escherichia coli shuttle
vector pKSD6-1 consisted of producing the gene from pcWoriP450cam plasmid by
polymerase chain reaction (PCR), cloning the gene into the commercially
available pCR2.1 TOPO vector (Invitrogen Corporation, Carlsbad, CA),
obtaining the CYP101 gene from the recombinant Topo+CYP101 plasmid
ligating it with the pKSD6-1 plasmid and transforming it into Escherichia coli.
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Analysis of the pKSD6-1 plasmid showed that cloning the CYP101 gene from
the plasmid pCWori+CYP101 into pKSD6-1 was not a feasible task because of
the unavailability of appropriate restriction sites to directly insert the gene into the
vector. It was therefore essential to use an intermediate vector, in this case the
commercially available pCR2.1 TOPO in order to achieve this end. The CYP101
gene was produced from the pCWori+CYP101 plasmid using Polymerase chain
reaction using primers P450 1F and P4501R that were designed based on the
standard design conventions stated in Sambrook Cloning Manual. [6]
The PCR product of CYP101 gene was analyzed using gel electrophoresis and the
gene was cloned into the pCR2.1 TOPO vector and transformed into the
Top10F’ chemically competent Escherichia coli cells (Invitrogen, Carlsbad, CA).
Among the various positive clones the one which yielded the CYP101 gene (1.4
kbp size fragment) upon restriction analysis was selected. This recombinant
plasmid was named 3-TOPO+CYP101.
The sequence of CYP101 that was amplified using P4501F and P4501R primers
was inserted into the gene sequence of the commercially available pCR2.1 TOPO
and a recombinant gene sequence of the 3-TOPO+CYP101 was created. This
recombinant gene sequence was analyzed using the NEBcutter V2.0 tool for the
appropriate restriction sites to clone the CYP101 gene into pKSD6-1.
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Upon analysis, the ApaI site was found to be the most suitable site for use in
both the vector and the insert. Both the vector pKSD6-1 and the plasmid
containing the insert 3-TOPO+CYP101 were restricted with ApaI to get the
desired “sticky” ends. The recombinant cytochrome P450cam and pKSD6-1 was
then transformed into Escherichia coli (DH5α) cells and a positive clone was
isolated. The double resistance of pKSD6-1 to ampicillin and chloramphenicol
antibiotics was used in selecting the positive clone.
The positive clone containing the recombinant CYP101 and pKSD6-1 was grown
and the cytochrome P450cam enzyme production was induced in the cells using
IPTG (Isopropyl β-D-thiogalactopyranoside). The protein extract from the cells
was analyzed using spectrophotometry, camphor binding and carbon monoxide
binding assays. These analyses revealed that the CYP101 gene has been cloned
into the pKSD6-1 shuttle vector and the enzyme that was produced was in its
inactive form. This present work is a detailed compilation of the experimental
procedures undertaken and analysis of the results.
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Chapter 2

LITERATURE REVIEW

2.1 Cytochrome P450
Background
Cytochrome P450 enzymes are a family of b-type heme containing proteins, their
ubiquity is evident by their presence everywhere in nature from Archaebacteria to
humans with the exception of enterobacteria. As of January 18, 2004 the number
of named cytochrome P450s include 1277 animal sequences, 1098 plant

sequences, 207 lower eukaryote sequences and 461 bacterial sequences.
That is a total of 3043 different named sequences and there are many more to be
named. [7,8]
The name P450 was given to indicate a pigment (‘P’) with a heme Fe2+-carbon
monoxide complex having an absorption spectral band at 450nm. The
cytochrome P450 enzymes catalyze monooxygenation of a number of aromatic
and aliphatic compounds in numerous metabolic and biosynthetic pathways. In
the biodegradative pathways of the eukaryotes they are responsible for the
metabolism of most xenobiotics as well as pharmaceuticals. This is important
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because though the oxidation of the xenobiotics is a prelude to their excretion
sometimes they get converted into reactive metabolites that cause deleterious side
effects. [9,10]
In plants they play active roles in herbicide resistance and biosynthetic pathways
such as morphine biosynthesis, in fungi they are involved in the antibiotic
synthesis; they synthesize resistance to plant toxins in insects and in the metabolic
and synthetic pathways of bacteria. The most common reaction catalyzed by the
cytochrome P450 is hydroxylation but forms that catalyze epoxidation,
dealkylation and sulfoxidation are also known. The P450 reaction generally
requires two electrons (which are provided by its redox partner), dioxygen and
two protons. [7]
There are three classes of P450 systems (shown in Figure 4); Class I are three
component protein systems in which the redox partners consist of NADHdependent FAD containing ferredoxin reductase and ferredoxin, examples of the
class I P450s are most bacterial and all eukaryotic mitochondrial P450s. Class II
P450 systems such as the eukaryotic microsomal (like those associated with the
endoplasmic reticulum) are two component systems in which the redox partner is
the NADPH-dependent diflavin (containing FAD and FADH) reductase. Class
III consists of a single component, which is a fusion of both the components,
representative of such a system, is the bacterial P450BM3. [7]
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Figure 4: Various classes of P450 systems. [7]
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Reactions catalyzed by Bacterial P450s
P450s contain an obligate heme cofactor that is linked to the peptide backbone of
the protein via a thiolate ligand provided by a cysteine residue. This cofactor
allows the enzyme to activate molecular oxygen to produce a high valent iron-oxo
species that is a powerful oxidant and enables these enzymes to perform a range
of oxidative transformations. Differences in the substrate specificities of the
various P-450s come from the different peptide backbones. Escherichia coli and
Salmonella typhymurium contain no P450s at all. The Table 1 lists the various types
of reactions catalyzed by the bacterial P450 enzymes, the species of their origin
and the various substrates they act upon. [11]
Comparison of the bacterial and mammalian cytochrome P450s
Rheinwald and Gunsalus (in 1973) were the first to show that the genetic
information for the proteins involved in camphor degradation is located on a
plasmid. There are some similarities between the membrane bound mammalian
mitochondrial steroid hydroxylating systems such as CYP11A1, CYP11B1,
CYP11B2 and the bacterial CYP101 systems. The mammalian systems receive
reduction equivalents from NADPH via membrane–associated adrenoredoxin
reductase (AdR) and adrenodoxin (Adx), a soluble [2Fe-2S] cluster containing
ferredoxin while the CYP101 system receives NADH via an FAD-containing
putidaredoxin reductase (PdR) and a [2Fe-2S] cluster-containing ferredoxin,
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Table 1: Reactions catalyzed by
bacterial P450s [11]
Enzyme

Gene

Reaction catalyzed

Substrate

Product

CYP101

Original
Host
Organism
Pseudomonas putida

P450cam

Stereo
hydroxylation

specific

(1R)-(+)camphor

5-exohydroxycam
phor

P450terp

CYP108

Pseudomonas species

selective

α-terpineol

P450lin

CYP111

Pseudomonas species

selective

Linalool

P450cin

CYP176
A1

Citrobacter braakii

Stereo
hydroxylation
Stereo
hydroxylation
Stereo
hydroxylation

selective

Cineole

P450camr
P450PicK

Rhodococcus sp
CYP107L
1

(1R)-(+)camphor

Streptomyces venzuelae

1. Hydroxylation
Of the C-10 and/or C-12
position .
2. Dehydroxylation
of the 12membered
macrolide at C-10
position followed
by the
hydroxylation at
the C-12 position.

Streptomyces spheroids
Streptomyces niveus

Hydroxylation

CYP119

Sulfolobus solfataricus

Hydroxylation

Long-chain fatty
acids

CYP102
A1

Bacillus megaterium

Hydroxylation

Rhodococcus ruber

Bioremediation
industrial
wastes
hydroxylation.

P450sca

Streptomyces carbophilus

P450EpoK

Sorangium
cellulosumSMP44

Lowering cholestrol by
Hydroxylation
using
pravastatin
In vitro epoxidation

Long chain fatty
acids
Methyl and ethyl
t-butyl etherand
methyl t-pentyl
ether.
cholestrol

P450NovI

Thermop
-hilic
P450
P450BM
3
P450Eth
B
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Macrolides

6-endo
hydroxycam
phor
Methymycin
Neomethym
ycin
Novamethy
mycin
14membered
macrolide
,picromycin

L-tyrosine
βhydroxytyros
ine

of
by

Epithilone D

Epithilone B

putidaredoxin. Figure 5 shows a schematic presentation of the soluble bacterial
CYP101 system and of the mammalian mitochondrial CYP11A1 system. Arrows
indicate the possibility of transferring of first electron to the heterologous P450.
[10]
Though the electrons can be transferred to a heterologous P450 (i.e. CYP101 or
CYP11A1) by putidaredoxin and adrenodoxin, the ferredoxins in the systems
cannot substitute for each other. Even though the ferredoxins cannot substitute
each other it has been shown that a system containing PdR, Pdx and microsomal
P450 CYP2B4 converts substrate effectively. Observed reaction rates of both the
systems range from 300 per minute for the CYP101 to 100 per minute for the

Figure 5: Electron transfer systems in CYP101 and CYP11A1 [10]
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CYP11A1, (catalyzes the first step in the conversion of cholesterol to
prenenolone). The difference in the reaction rates can be attributed to the
different velocities, which are the defining point of the fast bacterial and the slow
mammalian P-450 systems. [10]

Primary structures of the two ferredoxins reveal a 40% structural similarity with
38 identical amino acids and 18 conservative substitutions. When the primary
structures of both the ferredoxins are aligned, the [2Fe-2S] cluster-coordinating
residues that consist of four residues in both the proteins are found at the same
relative positions. Both Adx and Pdx are examples of vertebrate-type ferredoxins
and their tertiary structure reveals the same overall topology. The Figure 6 gives

Figure 6: 3D structures of Adx (top)
and Pdx (bottom). [10]
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the 3D structures of Adx and Pdx. Interaction sites of the mitochondrial
cytochrome P-450s are different than those of the CYP101. There is a major
difference in the C-terminal of both the ferredoxins, Adx has an extended Cterminal region and it does have an aromatic residue, which is the very important
W106 (Tryptophan) in Pdx. These are a few of the differences and similarities
between the two P-450 systems. [10]
Properties
Crystalline P450cam contains one heme per 46,000 molecular weight; it has one
mole of aspartate or asparagines as its NH2 (amino) terminal amino acid. It is
completely homogenous when examined by electrophoretic mobility and
hydrodynamic properties. It gives a single protein band over a pH range of 4.0 to
8.8 in a cellulose acetate strip electrophoresis. It has an isoelectric point at a pH of
4.7. Molecular weight of P450cam varies between 44,000 and 46,000. The purified
P450cam possesses a single molecule of ferriprotoporphyrin IX (heme) as a
prosthetic group. The heme can be removed by several methods and the
apoprotein thus obtained can be reconstituted to active P450cam with a
commercial or 57Fe-replaced heme. [12]
The α and β bands of oxidized form of P450cam shows absorption spectra at 571
and 538nm respectively. The Soret band is at 417nm; a shoulder or γ band is at
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365nm, the aromatic amino acid content at 280nm with a shoulder at 290nm.
Reduction of P450cam with dithionite causes a shift in the Soret band from 417nm
to 411 nm, the α and β bands are fused into a single absorption band at 540nm.
The amount of active P450cam in the sample is directly proportional to the Soret
absorption band. [12]
Reduced P450cam reacts with carbon monoxide to form a complex and causes the
Soret maximum to shift to 446nm; the α and β bands are fused at 550nm.
Carbon monoxide doesn’t alter the absorption spectra of the ferric (oxidized)
P450cam. Cytochrome P450cam is stabilized by the addition of camphor both
during purification and storage. [12]
Camphor free enzyme solutions show a gradual loss of enzymatic activity on
storage for long periods of time compared to the camphor bound ones. The
camphor bound enzymes are more stable because the binding of camphor the
enzyme’s natural substrate helps it preserve its tertiary structure. Lower protein
concentrations augment the loss in enzymatic activity. Camphor bound enzyme
has absorption maxima at 280, 392 and 643 nm. Addition of dithionite to an
anaerobic solution reduces the heme and the spectral maxima shift to 409nm and
545nm. When carbon monoxide is bubbled through the reduced enzyme, it
results in the absorption maxima to 446nm and 552nm. [12, 13]
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Phenylimidazoles inhibit P450cam activity at low concentrations and replace the
substrate. DPNH (diphosphopyridine nucleotide dehydrogenase) and KCN
(Potassium Cyanide) at high concentrations are inhibitory to the enzyme. In the
absence of camphor, a high concentration of DPNH causes permanent damage
to P450cam that is irreversible. In the presence of camphor P450cam is slowly
reduced by camphor. Activation of P450cam by glycerol is directly proportional to
its concentration. Sulfhydryl compounds such as cysteine, homocysteine, and
thioglycolic acid, glutathione and cystathione increase the activity of the enzyme
which probably is due to the conversion of the small amounts of enzymatically
inactive P-420 present to P-450cam. [12]
Crystal Structure
Crystals obtained from the ammonium sulfate solutions in the orthorhombic II
form provide good details about the structure of the enzyme. P450cam is an
asymmetrically shaped protein resembling a triangular prism of approximately 30
Ǻ with a maximum dimension of 60 Ǻ. There are twelve helical segments labeled
from A to L which dominate the structure and account for ~45% of the residues.
Four anti-parallel β pairs make up about 15% of the structure. There are no
parallel β pairs or extended sheet structure. The helices are arranged in three
layers stacked on top of one another and the heme is embedded in the layers. The
regular triangle shape of the enzyme is a result of the efficient packing of four
molecules in a unit cell; a reason for the low water content of the crystals. [14]
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The helices E, F, G, I form an antiparallel Greek key helical bundle; a common
structural motif found in globins, cytochrome c, etc. Helices L and I are almost
parallel to one another; helices D and L are also in approximate parallel
alignment. The remainder of the structure is a mix of helices interspersed with β
pairs. The number of residues in helical conformation is equal in the N and the C
terminal halves of the molecule while majority of the β structure is in the C
terminal domain. [14]
The heme is located between the proximal L helix and the distal I helix. The
proximal helix runs along the molecular surface while the distal helix runs
through the center of the center of the molecule. The heme is approximately 8Ǻ
away from the surface but it is not exposed to the bulk solvent. The hydrogen
donors such as Arg112, Arg299, His35, Gln108, Asp297 and a water molecule
surround the heme propionate groups. One of the heme propionate groups
forms an unusual interaction of carboxyl-carboxyl hydrogen bond with the side
chain of Asp297 and the Arg299 forming an ion pair with the propionate with its
guanidium group only 4.0 Ǻ away from the Asp297 carboxyl group, its positive
charged counterion thus aiding in stabilization of the carboxyl-carboxyl hydrogen
bond. [14]
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Catalytic cycle of cytochrome P450cam
Cytochrome P450cam (CYP101) catalyzes the insertion of one oxygen atom from
O2 into camphor thereby converting it into 5-exo- hydroxycamphor; this is the
first step in the camphor catabolism by the soil bacterium Pseudomonas putida.
There are two electrons required for the camphor hydroxylation by CYP101,
which come from the oxidation of NADH, which is in turn catalyzed by
putidaredoxin reductase (PdxR). A Cys4Fe2S2 ferredoxin, putidaredoxin (Pdx)
shuttles the electrons from PdxR to CYP101. [15]
The catalytic cycle of Pseudomonas putida P450cam (as shown in Figure 7) consists
of reversible substrate binding, which converts the six-coordinate, low-spin met
form of the protein to the five-coordinate, high-spin FeIII camphor complex,
thereby increasing the reduction potential of the heme iron atom. The addition
of the first electron reduces the enzyme to the five-coordinate FeII camphor
complex. Oxygen binds to the five-coordinate FeII camphor complex and gives
the six-coordinate ferrous-dioxy (FeII-O2) intermediate. Addition of a second
electron and two protons followed by cleavage of the oxygen-oxygen bond
produces a molecule of water and an oxidizing species, the so-called activated
oxygen intermediate; and insertion of the iron-bound oxygen into the substrate
produces 5-exo-hydroxycamphor and product is released. [16]
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Figure 7: Catalytic cycle of Pseudomonas
putida P450cam [17]
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Putidaredoxin reductase and Putidaredoxin
There are two types of electron transfer systems associated with
monooxygenation reactions catalyzed by P-450s 1) those requiring a flavoprotein
dehydrogenase, an iron-sulfur protein, and the P-450; and 2) those requiring a
FAD and FMN containing flavoprotein dehydrogenase and the P-450. An
example of the former class is P-450cam and they are usually associated with
mitochondrial steroidogenesis, while the latter is associated with microsomal drug
or steroid metabolism and P-450BM3. P-450cam has been cloned, sequenced, and
expressed in an active form in E. coli thereby providing a useful tool for studies of
the electron transfer and monooxygenation reaction utilizing site-directed
mutagenesis. [18]
Active site mutants of CYP101 have been shown to oxidize a wide range of
compounds. CYP101 activity requires two proteins, a flavoprotein putidaredoxin
reductase (PdxR) that accepts two electrons from NADH and one at a
timetransfers these to cytochrome P450cam through the mediation of an ironsulfur protein putidaredoxin (Pdx) whose role is to transfer the electrons from
NADH cofactor to CYP101 enzyme. [19]
The Figure 8 illustrates the flow of electrons from NADH to P450cam. In the first
electron transfer reduced Pdx combines with a ferric-camphor bound P450cam
and reduces it to the ferrous form. In the second electron transfer the reduced
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Figure 8: Electron Transport from PdR to P450cam Mediated by Pdx. [20]
Pdx forms a binary complex with oxyferrous, D-camphor bound P450cam and
leads to the formation of the products 5-exo-hydroxycamphor, water, oxidized
Pdx and D-camphor free ferric P450. Pdx plays the role of an ‘effector’ in the
second electron transfer in addition to being an electron carrier. [19]
There are three possible mechanisms for the flow of electrons from PdxR to
P450cam; these include the cluster, Pdx shuttle and the transient cluster
mechanisms. In the cluster mechanism the PdxR/Pdx/P450cam complex forms
and survives for one or more turnovers. This indicates that both the electrons
from one molecule of NADH move through the flavin of PdR to sequentially
reduce the same Pdx and P450cam molecules. [20]
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The shuttle mechanism doesn’t require the formation of a complex of all the
three proteins during the catalytic cycle; it involves the reduction of the oxidized
Pdxox by PdxR and release of the reduced form of Pdxr into the solution and
reduction of P450cam by the binding of Pdxr. The transient cluster mechanism is a
hybrid of the prior two mechanisms. In this one molecule of Pdx remains bound
to the P450cam throughout one or more catalytic cycles. The cycling of Pdxox to
Pdxr occurs via a transient association of fully reduced or one electron reduced
PdR to Pdxox /P450cam complex. Two possible mechanisms for transfer of
electrons from PdR to P450cam are shown in Figure 9. [20]
There is evidence in support of the shuttle mechanism which includes the ability
of PdxR to reduce Pdx in the absence of P450cam and also the fact that Pdxr is
able to carry out both the electron transfer steps to P450cam in the absence of
PdxR. In addition mutagenesis studies have revealed that the binding sites on Pdx
for the PdxR and P450cam overlap, indicating that PdxR and P450cam cannot bind
simultaneously to Pdx. Though the fusion proteins of PdxR, Pdx and P450cam
have an efficient turn over, the shuttle mechanism is probably what fits best in
the overall picture. [20]

26

Figure 9: Possible mechanisms for
transfer of electrons from PdR to
P450cam The oval represents the
porphyrin ring of camphor-bound
P450cam [20]
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Substrate specificity of P450cam
Cytochrome P450s catalyze a range of oxidative transformations such as carbon
hydroxylation, heteroatom oxidation, Π (pi) bond oxidation, and hydrocarbon
desaturation. Despite differences in phylogenetic origin, cellular localization,
electron donor partners and substrate specificity of P450 enzymes their active
sites and catalytic mechanisms are remarkably similar. In the catalytic cycle of the
P450 enzymes, the primary function of the enzymes is to promote the formation
of ferryl species and to bind and orient the substrate in its proximity. The chemo
and the regio-specificity of substrate oxidation are determined by the intrinsic
reactivities of the substrate sites that are accessible to the ferryl species in the
enzyme substrate complex. [21]
The oxidation of the organic substrate is caused by the coupled turnover, in
addition to this the P450 enzymes undergo uncoupled turnover to produce
oxygen, hydrogen peroxide and water. The uncoupling of the NAD(P)H,
(chemically reduced form of Nicotinamide Adenine Dinucleotide Phosphate)
consumption from the organic substrate oxidation is due to dissociation of super
oxide (O2-*) from the ferrous dioxy complex, and/or reduction of the final ferryl
species to water by electrons provided by NAD(P)H. Uncoupled turnover is low
in resting enzyme but it greatly increases with the binding of some ligands and
substrates; it is a substrate dependent catalytic process that produces reduced
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oxygen rather than organic metabolites. Figure 10 shows possible places in the
Pseudomonas putida catalytic cycle where uncoupling can occur [21]
The P450 enzymes that have hydrophobic active sites have very broad substrate
specificity with preference for lipophilic substrates; these facts suggest that the
binding of the P450 substrates is governed by hydrophobic and steric factors.
Catalytic turnover is defined as the NADH-and substrate dependent formation of
either organic or reduced oxygen metabolites. Binding of the substrates to the
cytochrome P450cam active site is a prerequisite for catalytic turnover. Saturation
of the active site of P450 cam with camphor results in the complete conversion of
the enzyme from low spin state to high spin state.

Figure 10: Catalytic cycle of cytochrome P450, showing the individual steps at
which uncoupling can occur. [21]
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Also the binding affinity and the extent to which the enzyme is converted to the
high spin state by a saturating concentration of the substrate are correlated.
NADH consumption provides a direct measure of the extent of catalytic
turnover engendered by the binding of a substrate to P450cam. [21]
The diversity of the substrates for the P450 enzymes is not only due to the
multiplicity of the isoforms but because of the fact that they are able to catalyze a
broad range of P450 dependent transformations with a broad range of substrates.
It is important to understand the substrate specificities of P450 enzymes for the
design and construct of P450 enzymes with tailored specificities .The availability
of the high resolution crystal structures of the four microbial P450 enzymes
makes the bacterial enzymes amenable to analysis of the features that control
substrate and reaction specificity. [22]

Two methods have been used to predict the substrate specificities of the well
characterized P450cam; one involves the use of molecular dynamic simulations to
predict the regio-and stereo specificity of the products and the other includes the
three-dimensional active site constrained screening procedures which are used to
identify the compounds that fit within the active site and therefore are possible
substrates. Both these processes necessitate the dissection of the catalytic process
into discrete steps in order to correlate the effects of structure on individual
branch points in the process. [22]
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Heavily chlorinated compounds such as chlorinated benzenes such as
hexachlorobenzene (HCB), pentachlorobenzene (PeCB), biphenyls and dioxins
are some of the most problematic environmental pollutants. Degradation of the
most heavily chlorinated benzenes requires initial reductive dehalogenation
followed by oxidation by the dioxygenase pathway. Pathways that involve
oxidation of chlorohydroquinones by action of flavin dependent monoxygenases
degrade polychlorinated phenols. Then these reactive chlorohydroquinones are
readily dehalogenated by hydrolytic or reductive mechanisms. Ring cleavage in
polychlorinated benzenes occurs only after most of the chlorines are removed
resulting in a more facile pathway. Cytochrome P450cam has been genetically
engineered to act on compounds such as 1,2-DCB (dichlorobenzene), 1, 3-DCB,
1,4-DCB, 1,3,5-TCB (trichlorobenzene), 1,2,4,5-TeCB (tetrachlorobenzene),
PeCB (pentachlorobenzene) and HCB (hexachlorobenzene). [23]
The wild type monooxygenase cytochrome P450cam has a low activity for
oxidation dichlorobenzene and trichlorobenzene to chlorophenols and no activity
for heavily chlorinated benzenes. Increasing the active site hydrophobicity with
Y96F (Tyr to Phe) increased the activity of CYP101 causing the conversion of
the PeCB and HCB slowly. Also decreasing the space available at the top of the
active site with the F87W (Phe to Trp) mutation forces the substrate to be bound
closer to the heme and results in further increase in activity. [23]
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Cytochrome P450cam has been also engineered to oxidize gaseous alkanes like
butane and propane to butan-2-ol and propan-2-ol by reducing the substratebinding pocket. Using bulky amino acid substitutions reduced the size of the
substrate pocket and the enzyme-substrate binding was improved. A picture of
the active site of P450cam is shown in Figure 11. [24]
Engineering the active site topology for accommodation of different alkanes can
enhance activity, selectivity and coupling efficiency of alkane oxidation by
CYP101. Reduction of the active site volume using the mutations Y96F (Tyr to
Phe)–V247L (Val to Leu) showed a four-fold greater activity for hexane
compared to 3-methylpentane. When the active site was larger as a result of the
Y96A (Phe to Ala) –V247A (Valine to Ala) double mutation 3-methylpentane
was oxidized twice as fast as hexane. [25]
Styrene was weakly bound to the wild-type P450cam; the binding was strengthened
in the Y96F (Tyr to Phe) mutant, and again in Y96A (Tyr to Ala) mutant. This
strengthened binding in mutants is a result of the removal of the hydroxyl group
of tyrosine to generate a more active hydrophobic site that can interact better
with styrene. [26]
Selective catalytic oxidation of simple alkanes under mild conditions is one of the
more difficult chemical reactions to achieve using conventional synthetic
methods. Cytochrome P450cam was engineered to oxidize various simple alkanes
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Figure 11: Active site of the P450cam enzyme with camphor bound in it [24]
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like hexane, heptane, 2-methylpentane, 3-methyl pentane and 2-methylhexane.
Since the substrate-binding pocket of cytochrome P450cam is mostly lined with
hydrophobic residues with the exception of tyrosine 96, this was changed to
alanine (Y96A) and phenylalanine (Y96F) to suit the hydrophobic nature of
alkanes. The mutants showed an increased activity towards the alkanes proving
the fact that increasing the hydrophobicity promotes alkane oxidation. Linear
alkanes showed higher product formation rates with the Y96F and Y96A mutants
than the branched ones. [27]
Polyaromatic hydrocarbons (PAHs) are hazardous and recalcitrant environmental
contaminants mainly derived from anthropogenic pyrolysis of organic matter
such as fossil fuel consumption and coal refining processes. These are
procarcinogens and they are converted into highly carcinogenic oxidation
products by heme-dependent cytochrome P450 enzymes such as CP1A1.PAH
oxidation activity of P450 enzymes is of wide interest because P450s are utilized
in the initial oxidation step of biodegradation of PAHs. [28]
The cytochrome P450cam has been used to oxidize a variety of unnatural
substrates. Its mutant Y96A not only increases the hydrophobicity of the
substrate pocket but also creates space for the binding of substrates larger than
camphor. These two are important factors that enhance the ability of P450cam to
act on PAHs. Replacing Y96 with hydrophobic residues like Gly, Ala, Val, Phe
and further testing the mutants on naphthalene and pyrene have revealed that the
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mutants oxidize the substrates faster than the wild type. Naphthalene is oxidized
1- and 2-naphthol via 1,2-oxide intermediate and pyrene gave a 1,6- and 1,8pyrenequinone. [29]
The wild type cytochrome P450cam enzyme has very low activity with polycyclic
aromatic hydrocarbons like phenanthrene, fluoranthene, pyrene and benzo [a] –
pyrene where as the mutants (with mutations at F87 and Y96) show increased
activity on the same substrates. Hydrophobic substitutions at Y96 broadens the
P450cam substrate range through two effects 1) increasing the active site
hydrophobicity promotes binding of organic molecules and it also reduces
uncoupling by not favoring the entry of water molecules into the active site 2)
Y96 also forms a part of the substrate access channel, therefore hydrophobic
substitutions at this residue may promote binding of hydrophobic molecules like
pyrene. [29]
Cloning of the Cytochrome P450cam gene into Escherichia coli
Cloning of the cytochrome P450cam gene involved the localizing of the camC gene
within the PstI and HindIII fragment as shown in Figure 12, this gene is
responsible for the production of the P450cam enzyme. The primary amino acid
sequence of P-450cam has a 412 amino acid sequence that corresponds to a gene
length of 1236bp. Top panel of the restriction map of the 2.2-kilobase pair
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Figure 12: Restriction maps of pKG3OO and its derivatives. [3]
CAM plasmid fragment containing the cytochrome P-450cam gene shows a
heavy line representing the cytochrome P-450cam gene in Figure 12. The bottom
panel indicates the various constructions used. Regions between the circles
represent CAM plasmid DNA, where 0 and 0 are symbols for PstI and HindIII
sites, respectively. Gene symbols are as follows: tet-tetracycline resistance gene;
amp-ampicillin resistance gene, 0-lactamase gene; lacZ, β-galactosidase gene.
Arrows indicate the direction of transcription. [3]
CAM plasmid was sub cloned into pUC13, pEMBL8+ and pEMBL9+ so as to
increase the yield of the plasmid DNA because these vectors had a higher copy
number than their parental vector pBR322 from which pKG300 was derived. In
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these various sub clones the camC gene was transcribed from the lac promoter,
thereby increasing the yield of the cloned protein than that produced from the β
lactamase gene promoter in pBR322. [3]
The entire cytochrome P450cam gene from the PstI to the HindIII site that was
1578bp was sequenced; this also included a flanking sequence and some DNA on
the 3′ end. The Figure 13 shows a heavy line representing the cytochrome P450cam gene. Arrows in Figure 13 indicate the direction and extent of sequencing
from each restriction site. Only restriction sites used for sequencing are shown,
PstI (P), BglI (Bg), RsaI (R), BamHI (B), EcoRV (E), BstXI (B X), BstEII (BE),
Sal1 (SI, and HindIII (H). [3]

Figure 13: Sequencing strategy of the cytochrome P-450 gene.[3]
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Figure 14 shows nucleotide numbering begins with the first nucleotide of the PstI
site which is 155 nucleotides 5' to the cytochrome P-450cam gene. Amino acid
numbering begins with the first Thr (Threonine) and the initiating Met
(Methionine) of the cytochrome P-450cam and putidaredoxin reductase genes,
respectively. The underlined nucleotides refer to putative Shine-Dalgarno
sequences. The boxed amino acids and nucleotides indicate differences between
the protein sequence and the nucleotide-derived amino acid sequence
Thus the cytochrome P-450cam gene was cloned into Escherichia coli, its amino acid
and nucleotide sequence were determined and it was demonstrated through
various analysis that the cytochrome P-450cam enzyme from Escherichia coli and
Pseudomonas putida is indistinguishable with respect to its optical spectrum,
molecular weight, catalytic activity and N-terminal sequence. Placement of the
camC gene behind the lac promoter in Escherichia coli vectors enabled the camC
gene behind the lac promoter in Escherichia coli vectors enabled the production of
the enzyme in large quantities. When the gene was oriented opposite of the
direction of the vector promoter in Escherichia coli, P-450cam protein was
undetectable by the reduced CO (Carbon monoxide)-difference spectral analysis.
[3]
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Figure 14: The complete nucleotide sequence of the cytochrome P-450 gene and
a 5' portion of the putidaredoxin reductase gene. [3]
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2.3 Shuttle vectors
Introduction
Shuttle vectors consist of double replicons, in which one half of the plasmid
allows replication in an enteric bacterial host and the other half allows replication
in any other host from which the other replicative region has been derived. These
vectors are used in transferring recombinant plasmids from Escherichia coli into
non-purple Gram (+) bacteria and most eukaryotic hosts. In these shuttle vectors,
one half of the vector is derived from Escherichia coli specific vectors, the second
half comes from often small cryptic (but ideally multicopy) replicons, which were
isolated from the individual host strain; they provide the oriV specific to the host
from which they were isolated. The two halves are then joined by DNA
manipulation, which is the reason why this approach is also referred to as double
replicon strategy. [30]

Rhodococcus-Escherichia coli shuttle vectors
The lack of plasmid vectors suitable for use in Rhodococcus has led several groups
to develop binary vectors, in which extant Rhodococcus plasmid is combined with
an Escherichia coli plasmid forming a vector that replicates in both cell types. Some
of these Rhodococcus-Escherichia coli shuttle vectors are given in the Table 2.
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Table 2: Rhodococcus-Escherichia coli shuttle vectors
RhodococcusEscherichia coli
Shuttle vector
pRHK1

Features

Reference

Has a cryptic plasmid pRC4, derived from [31]
Rhodococcus rhodochrous and a vector from
Escherichia coli with a kanamycin resistance
gene, pHSG298

pNC9503

Escherichia coli-Rhodococcus erythropolis shuttle [32]
vector with a unique restriction site for
XbaI. It has a kanamycin resistance gene and
a thiostrepton resistance gene .The origin of
replication is from Rhodococcus rhodochrous
plasmid pNC903

pNC9501

In addition to all the features in the [32]
pNC9503 it has two other unique restriction
sites for KpnI and EcoRI

pRF29

Cointegrate of pRF28 (StuI linearized) and [33]
pUC13 (SmaI linearized). Has ampicillin
resistance gene and chloramphenicol
resistance gene

pMVS301
pMVS302

and Escherichia coli–Rhodococcus shuttle plasmids [34]
have ampicillin resistance gene from
pBR322 and thiostrepton resistance gene

pKSD6-1

Rhodococcus-Escherichia coli shuttle vector [18]
containing ampicillin and chloramphenicol
resistance genes.
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Construction of the Rhodococcus-Escherichia coli shuttle vector pKSD6-1
The Rhodococcus-Escherichia coli shuttle vector pKSD6-1 is capable of replication in
both Rhodococcus and Escherichia coli and it was constructed as a deletion derivative
of the plasmid containing the sox genes The Rhodococcus sp. strain X309-11-15 was
used as a source of a 100-kb pSOX plasmid, and Rhodococcus sp. strain X309-10-2
(referred as 10-2) was the plasmid free derivative of the Rhodococcus sp strain
X309. [18]
pSOX∆1(52 kbp in size) was produced as the first deletion derivative of
the pSOX plasmid by selecting from the electrotransformed 10-2 strain
using DBT(Dibenzothiophene).Restriction of pSOX∆1 with EcoR1
produced five fragments, which were selected for the sox containing
genes using the Southern hybridization test. This pSOX∆1 was
introduced into 10-2 and further selection on DBT plates resulted in
pSOX∆2. [18]
pSOX∆2 was a 42kb fragment, a series of self defined manipulations like
the self ligation of a 30kb sox containing EcoRI fragment from pSOX∆2
gave pSOX∆3 which was capable of replicating in strain 10-2. A
chloramphenicol resistance (Cmr) gene was added to the rightmost 15-kb
XbaI-EcoRI fragment at the unique EcoRI site of pSOX∆3.To facilitate
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cloning, both the linearized vector and the XbaI-XhoI DNA fragment
containing the Cmr gene were blunt ended with dNTPs and Klenow
DNA polymerase I. [18]
Digestion with EcoRV and Xba I gave an 18.5-kb fragment which when
transformed into 10-2 and selection on chloramphenicol plates gave
several colonies that were analyzed. The analysis revealed the existence
of two populations of cells one containing the expected 18.5 kb plasmid
(pSOX∆4) and the other having a 9kb plasmid (pSOX∆5). [18]
pSOX∆6 was obtained by ligating the 4-kb KpnI fragment to the 3.5 kb
Cmr gene cassette, which was a blunt end ligation. Screening for the 7.5
kb pSOX∆6 revealed the deletion of 400bp in one derivative, which was
named as pSOX∆6-1. The entire process of constructing the deletion
derivatives is given in the Figure 15 below. In the Figure 15 the ability
of each plasmid to replicate (ori) or possess desulphurization activity (sox)
is shown at the right by the plus and minus signs. Cmr indicates the
chloramphenicol resistance marker gene derived from pRF29 plasmid
and --- in Figure 15 is the undefined boundary of deletion. [18]
pSOX∆6-1 was linearized by SphI and ligated to the Nae I site (within
the f1 origin) of the pBluescript II KS –plasmid. The pBluescript II KS –
plasmid provides the colE1 replication origin, a multiple cloning site and
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Figure 15: Construction of the
deletion derivatives of the pSOX
plasmid. [18]
the lacZα reporter gene for screening inserts in Escherichia coli (blue-white
selection) and Ampicillin resistance (Apr). The resultant plasmid was named
pKSD6-1. Figure 16 shows the shuttle vector that has been used for sacB
expression in Rhodococcus strain 10-2, the MCS, multiple-cloning site (expanded
region).It also shows the blunt-end cloning of the end-filled 3.8-kb BamHI
fragment of pUM28 plasmid containing sacB at the EcoRV site. [18]
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Figure 16: Construction of the pKSD 6-1 Rhodococcus-Escherichia coli shuttle vector.
[18]

2.4 pCWori plasmid
pCWori+ is a derivative of the plasmid pHSe5, it contains a pBR322 origin of
plasmid replication, the lac I gene, the β lactamase gene for conferring ampicillin
resistance and a bacteriophage origin of replication. The transcription and
translation regions contain a lacUV5 promoter and two copies of a tac promoter
cassette followed by a translation initiation region derived from the phage T4
lysozyme gene. This DNA sequence contains a 7 bp Shine-Dalgarno element
located three nucleotides 5′ of the initiation codon contained within an NdeI
restriction site. A trpA transcription termination cassette is located downstream
of the unique 3′ restriction sites.[39] pCW is a plasmid that over expresses the
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che W protein, it contains the che W gene from the pJL63 plasmid that has been
introduced into the pHSe5. In pCW the expression is under the control of the
tac promoter. [35]
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Chapter3

METHODS AND RESULTS

3.1 Introduction
The main aim of the project was to clone the CYP101 gene into a RhodococcusEscherichia coli shuttle vector and express the protein in a Rhodococcus bacterium.
On examining the MCS (multiple cloning site) of pKSD6-1 and sequence of the
cytochrome P450cam (CYP101) gene, it was found that cloning of the cytochrome
P450cam gene directly into the chosen vector pKSD6-1 was not possible because
of the unavailability of compatible restriction sites on the insert and the vector.
This necessitated the usage of the commercially available pCR2.1-TOPO vector
as an intermediary. The CYP101 was first cloned into pCR2.1-TOPO, and then
the CYP101 gene was restricted with a suitable restriction enzyme and cloned
into pKSD6-1.

3.2 Production of the gene from pCWori plasmid containing CYP101 using
PCR
The pCWori+CYP101 plasmid (Figure 17) was obtained from Prof. Paul R. Oritz
de Montellano (University of California, San Fransisco, CA). The following
factors were taken into consideration while designing the primers. The MCS of
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Figure 17: pCWori+P450cam

the vector pKSD6-1 was observed and all the available sites on that were
analyzed for suitability. The suitable restriction sites on the MCS met the
following conditions
•

They were not present anywhere on the insert, i.e. CYP101 sequence

•

They should have sufficient activity in the same NEB buffer that will be
used while setting up the restriction reaction.

Using the CYP101 sequence from the gene bank the forward (P450 1F) and the
reverse primers (P450 1R) were designed with ApaI and Sac I restriction sites
included in the P4501F and P4501R respectively as they met all the
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aforementioned conditions. The feasibility of the designed sequences was then
tested using the primer design link in the Invitrogen website (see [36])
The sequences of the designed primers are given below:
P4501F (5′-3′): TAG GGG CCC ACA ATG ACG ACT GAA ACC ATA CA
P4501R (5′-3′): CAT GAG CTC AAG CTT TGG ATA GCG GTGG
The primers were obtained from Invitrogen and their (10pmol/µL) solutions
were prepared. The PCR for the production of the P450cam gene was optimized
by setting up seven 30µL PCRs using buffers A, B, C, D, F, J, and N from the
Invitrogen PCR optimization kit. The protocol for this set of PCRs is given
below.
Protocol for the PCR to produce CYP101
5X Buffer: 6µL
10 pmolP 4501F ( Forwardprimer ) : 1.5µL 
Primers 

10 pmolP 4501R(Re verseprimer ) : 1.5µL 
DNA (CYP101 1:50 dilution of 383.25µg/mL): 3µL
25 mM dNTP: 0.6µL
Sterile water: 17.1 µL
Taq Polymerase: 0. 3µL
Total volume: 30µL mix contents by gently tapping
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Add Nujol oil: 10µL and mix the contents again by tapping.
The contents in the PCR vial were run in a thermocycler (Perkin Elmer Cetus
DNA THERMAL CYCLER, MA), using program files 90, 91 and 18, which
were programmed as follows:
File 90: 2.5 min at 94°C

File 91:

1 min at 94 o C 


o
2 min at 55 C  30 cycles of file 91


o
4 min at 72 C 

File 18: delay time 10 min at 72ºC
After all the programs in the thermocycler were completed, then the PCR vials
were removed and the reaction solution of 30µL was carefully pipetted using a
manual pipette and placed in another vial. 15µL of each of the PCR reactions
performed was run on a gel to test the presence of the desired CYP101 band. Gel
electrophoresis using agarose gel (0.7%) showed the fragment equal in size to the
P450cam gene, 1.4 kilobasepair (kbp) in six lanes; of these C, B, A, D, F, J were the
lanes on which the gene was seen better (in that order as seen in Figure 18) than
on others. The gene was excised from the gel using a clean sterile blade and DNA
was extracted from the gel using Wizard PCR preps DNA purification system
(Promega, CA). Both the insert and vector DNA were restricted with ApaI and
SacI to get the desired ‘sticky’ ends. The protocol for the restriction reaction is
given in Table 3.
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Figure 18:Gel showing the 1.4 kbp P450 gene from the PCR optimization
buffers.
Table 3:Protocol for the restriction reactions of insert and
vector
Insert

Vector

DNA (from C, D and A): 10µL

3.83µg/mL Vector DNA: 2µL

ApaI* (10000u/ml): 1µL

ApaI(10000u/ml): 1µL

SacI *(20000u/ml): 1µL

SacI(20000u/ml): 1µL

NEB4* (10X): 3µL

NEB4 (10X): 3µL

BSA* (100X): 0. 3µL

BSA (100X): 0. 3µL

Sterile water: 14.7µL(for PCR products) Sterile water: 22.7µL(for vector DNA)
Total: 30µL

Total: 30µL

*All the restriction enzymes and buffers used for the reactions were obtained
from the New England Biolabs, MA.
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3.3 Attempt to directly clone cytochrome P450cam into pKSD6-1
Since the complete restriction map of the vector pKSD6-1 was not known, the
experiments were devised on the basis of the available partial restriction map of
pKSD6-1. The DNA of the PCR products that was run and purified from the gel
and the vector DNA (pKSD6-1) were restricted with ApaI and SacI enzymes
The contents were mixed and placed in an incubator at 37°C overnight; the next
day they were subjected to gel electrophoresis. The insert gave the desired single
fragment of 1.4kbp but the vector gave three bands instead of the expected one
10.1kbp band (seen in Figure 19). It was therefore concluded that ApaI + SacI
together had three restriction sites on the pKSD6-1 plasmid. It was necessary to
investigate the number of restriction sites for each of the enzymes ApaI and SacI
so as to determine which restriction enzyme was cutting the vector more than
once to omit its use further during experimentation; therefore pKSD6-1 was
restricted with ApaI and SacI separately. ApaI was found have a single restriction
site on pKSD6-1 at the MCS where as SacI had three restriction sites on the
entire plasmid (shown in Figure 20)
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Figure 19: Gel analysis of the insert
and vector restricted with ApaI and
SacI
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Figure 20: Gel showing the restriction of pKSD6-1 w/ SacI (3) and Apa I (5)
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Also an attempt was made to construct a partial restriction map of the shuttle
vector. To this end the vector was digested with different enzymes available in
the laboratory. The gel analysis of the restriction reactions is given Figure 21.

3.4 Cloning of cytochrome P450cam into pCR 2.1 TOPO
After finding that CYP101 couldn’t be cloned into pKSD6-1 directly using
current primers/restriction sites; the alternative was to design new primers with
different restriction sites or to clone via a cloning vector such as commercially
available pCR 2.1-TOPO. A 50 µL PCR was performed this time different
restriction sites or to clone via a cloning vector such as commercially available
pCR 2.1-TOPO.
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Figure 21: Gel analysis of pKSD6-1 restricted with various enzymes.
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A 50 µL PCR was performed this time using only buffer C (that produced the
clearest band on the gel) for the production of the CYP101 gene; also another
PCR was set up for the control DNA given in the cloning kit. The control PCR
was set up as given in the TOPO TA cloning
Protocol for the 50µL PCR reactions

Buffer: 10µL
10 pmolP 4501F ( Forwardprimer ) : 2.5µL 
Primers 

10 pmolP 4501R(Re verseprimer ) : 2.5µL 
DNA (CYP101 1:100 dilution from midi prep): 5µL
dNTP (2.5Mm): 1µL
Sterile water: 28 µL
Taq Polymerase: 1µL
Total volume: 50µL mix contents by gently tapping
The products were tested for the presence of the respective genes using gel
electrophoresis as shown in Figure 22; the P450 band is not very clearly visible in
the Figure 22. After verification the bands were excised from the gel and purified
using the Wizard prep PCR purification system.50 µL of each DNA was eluted
after purification. The purified CYP101 and the control genes thus obtained from
PCR were cloned into the TOPO cloning vector, pCR 2.1-TOPO and
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Figure 22: Gel showing the CYP101 and the control genes
transformed into Top10F′ cells using the one shot chemical transformation
protocol given in the TOPO TA cloning manual.
100 µL of each transformation solution was plated on one LB (Luria broth) agar
plate (1/10 plate) containing 50 µg/mL ampicillin; the rest of each solution was
plated on to another one .All the four plates were incubated over night at 37°C.
The transformation was successful resulting in colonies on all plates.
Twenty colonies were picked from the CYP101 transformation containing agar
plates and two colonies were picked from the control plates and grown in 5mL of
LB containing 50 µg/mL ampicillin. The colonies were allowed to grow
overnight in the incubator at 37°C and 150 rpm. The next day, 3mL of each
culture was used and DNA from the culture was obtained using lysis by boiling
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method (boiling prep). The size of the recombinant pCR2.1 TOPO+CYP101
(shown in Figure 23) is 5.4 kbp; this was estimated using the sequences of the
plasmid pCR 2.1 TOPO and the PCR product CYP101.
Then this recombinant plasmid was analyzed using NEBcutter V2.0 software for
a suitable restriction site. The desired site was required to cut the recombinant
plasmid on the P450cam gene only and linearize the plasmid (Topo+CYP101).
NotI was the only site that was present once on the TOPO gene and absent on
the CYP101 gene (as shown in Figure 24), therefore it was chosen to restrict all
the recombinant DNA isolated from the twenty colonies.

Figure 23: pCR2.1 TOPO+CYP101 plasmid
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Figure 24: pCR 2.1 TOPO+CYP101
with NotI restriction

After a two-hour restriction reaction using the standard protocol all the samples
were analyzed on a gel. The gel revealed an unexpected 3.8 kbp band (shown in
Figure 25 (a) and (b)) instead of the expected 5.4 kbp. This meant that there was
no insert in any of the colonies. This fact was further confirmed by restricting the
recombinant plasmids with EcoRV, which has two restriction sites on the
recombinant plasmid pCR2.1TOPO+CYP101.
Another 50µL PCR was set up for the production of the CYP101 gene using the
protocol given previously. The CYP101 gene formed was verified using an
agarose gel. To clone the P450 gene into the TOPO vector 4µL of the direct
PCR reaction mixture was used; it was immediately transformed into Top10F′
cells. The transformants were plated on LB agar plates containing 50µg/mL
ampicillin, X-gal (5-bromo-4-chloro-3-indolyl-bD-galactoside) and 100mM IPTG
to facilitate blue/white selection. The plates were incubated overnight at 37°C.
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Figure 25: Gels showing the 3.8kbp band instead of the expected 5.4kbp in the
DNA isolated from twenty different colonies.
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•

After 24 hrs many colonies were found on each plate. Five colonies from
each plate were picked and grown in 5mL LB cultures containing 50µg
/mL of ampicillin. One mL of each of these cultures was stored at-80°C
in 20% glycerol. The rest of each of the culture was subjected to lysis by
boiling (adapted from Holmes and Quigley).

•

Using restriction analysis with NotI enzyme, the presence of the insert
was verified. Gel electrophoresis after restriction analysis revealed the
presence of the expected 5.4 kbp fragment (seen in Figure 26) on the gel.

The expected fragment of 5.4 kbp was seen only in the lanes containing the DNA
sample from colony 3, which was selected from the agar plates containing the
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1 Lambda EcoRI /HindIII
2
3
3-TO PO+CYP101 w /NotI
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Figure 26: Gel showing the presence of the 5.4 kbp linear TOPO+CYP101
plasmid
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recombinant TOPO+CYP101 transformants thereby proving the presence of the
gene in the recombinant plasmid of this colony. This colony was grown again in a
5mL LB culture containing ampicillin and a frozen stock containing 20% glycerol
was made from this culture using 20% glycerol and was stored at –80°C; this
stock was named 3-TOPO+CYP101.
3.5 Cloning of cytochrome P450 from 3-TOPO+CYP101 to pKSD6-1
A culture of the frozen stock of the 3- TOPO+CYP101 DNA was inoculated
into 5mL of LB containing ampicillin and was allowed to grow overnight in the
incubator with a shaker at 225rpm and 37°C. The culture was used as inoculum
for the 100mL culture containing 50 µg/mL ampicillin that was grown overnight
on the shaker at 225rpm and 37°C. The DNA was extracted from the 100mL
culture using midiprep. The presence of the insert was confirmed again by
restricting 3-TOPO+CYP101 using NotI and EcoRV enzymes (shown in Figure
27) All the restriction sites in the multiple cloning site of the vector were analyzed
for an enzyme suitable to act with ApaI for cloning the cytochrome P450cam gene
from 3-TOPO+CYP101. None of the sites on the MCS of the vector were found
to be suitable enough to act with ApaI for cloning.
Also analysis of the 3- TOPO+CYP101 plasmid revealed that there were two
ApaI sites flanking the cytochrome P450cam gene (shown in Figure 28), therefore
ApaI was chosen for restricting the cytochrome P450cam gene and ligating into
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Figure 27: Gel showing 3- TOPO+P450 w/ NotI and EcoRV

Figure 28: 3-TOPO+CYP101 plasmid showing ApaI sites flanking the
cytochrome P450cam gene.
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pKSD6-1. TOPO+CYP101 with ApaI gave two distinct bands on the gel one of
1.4 kbp (containing CYP101) and the other 4.0 kbp (shown in Figure 29).
3.6 Ligation of the insert into the vector
100µL solutions of the vector (pKSD6-1) and the insert (3-TOPO+CYP101)
were restricted with ApaI on a 0.7% agarose gel. After an overnight restriction,
the solutions were subjected to gel electrophoresis to get the desired 10.1-kbp
vector and 1.4+4.0 kbp insert band (Figure 30). The insert (1.4 kbp) and the
vector 10.1kbp bands were excised and were using Wizard PCR preps DNA
Purification Kit (Promega, WI). 50µL of DNA were eluted for each of the vector
and insert DNA from their respective bands.
The concentration of DNA was measured in the eluted solutions using
SPECTRAmax Plus384 (Molecular Devices, Sunnyvale, CA). The amounts of
DNA present in the vector and the insert solutions were 327.5ng and
249.75ngrespectively from the calculations based on the absorption spectrum of
the DNA samples.
•

300ng of the vector was the basis for the ligation reaction. Depending on
this the amount of insert required was calculated using the recommended
1:1 vector-insert ratio.
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Figure 29: 3-TOPO+CYP101 with /ApaI restriction
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Figure 30: Gel with insert and vector DNA.
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Lambda EcoRI/HindIII
pKSD6-1 w/ApaI
pKSD6-1 w/ApaI
3-TOPO+CYP101 w/ApaI
3-TOPO+CYP101 w/ApaI

Basis: 300ng vector
300ngvector × 1.8kbp 1
×
10.1kbp
1

= 53.465ng insert

(2)

The required volumes of the insert and vector were then reduced to much lesser
volumes in a DNA mini (JOUAN Nordic A/S, Denmark) at 1mbar pressure to
suit the total required volume of the ligation reaction (10µL). The ligation
reaction was placed on a vortex for overnight incubation at 4°C.
The protocol for the ligation reaction is given below
Vector: 6µL (6.55ng/mL)
Insert: 2µL (4.995ng/mL)
T4 ligase: 1µL
10X ligase buffer: 1µL
Total Volume: 10µL
After vortexing at 4°C overnight the ligation reaction was transformed into
chemically competent Escherichia coli (DH5α) cells. Transformed 3µL of the
reaction mixture into three samples of 50µL DH5α cells using chemical
transformation protocol. The transformants were plated on LB agar plates
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containing 30µg/mL chloramphenicol and 50µg/mL ampicillin. The plates were
incubated at 37°C for overnight growth.
After 24 hrs there were no colonies found on any of the plates. A single white
colony was observed after 48hrs, which was immediately picked and grown in
5mL LB containing 30µg/mL chloramphenicol and 50µg/mL ampicillin. Again
after another 48hr period at 37°C, growth was observed in the test tube. 2mL of
this culture was stored in 1mL vials with 20% glycerol at -80°C. The remaining
3mL culture was purified using Wizard Plus Miniprep (Promega, WI). The uncut
DNA was run on the gel to verify the presence of DNA. No DNA was found on
the gel.
•

Various attempts to clone the CYP101 from 3-TOPO+CYP101 to
pKSD6-1 were made after the first one failed. These included ligating the
vector and insert in ratios of 1:3, 3:1 (vector: insert), increasing the
quantities of the vector and insert ligated. These were unsuccessful as
well.

3.6 Production of the P450cam enzyme
When the frozen cells that were stocked from the first transformation were
cultured in 100mL LB containing 30µg/mL chloramphenicol and 50µg/mL
ampicillin to give another attempt at purifying the gene, it was observed that the
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culture was pink in color. Purified P450cam enzyme has a brown color and a
comparison to the color of the recombinant culture indicated that further
investigation for the presence of the enzyme was needed.
The cytochrome P450cam enzyme was extracted from the Escherichia coli containing
the recombinant gene by using the following protocol.
The Escherichia coli (DH5α) cells were grown to an O.D. (optical density)
of 0.6 at 37ºC, the flask containing the culture was transferred briefly to
an incubator at 30ºC for fifteen minutes. Adding 1mM IPTG and
incubating the cell culture at 30ºC and 90rpm for 36 hours induced the
production of cytochrome P450cam from the recombinant pKSD61+CYP101 plasmid.
Then the cells were harvested by centrifuging in the Sorvall RC-5B
Refrigerated Super speed centrifuge (Dupont Instruments, DE) in an SS34 rotor at 13.5K for twenty minutes to obtain the cell mass. Excess
supernatant was removed from the cells using a pipet.
•

The cell mass obtained: 1.21g

•

Volume of the 50mM Tris HCL added at pH 8.0: 4.84 mL

•

Amount of 0.5mM EDTA added to make an overall 1mM solution:
9.68µL
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•

19.36mg of lysosyme (Sigma-Aldrich, MO) was added to this mixture
and then the mixture was incubated on ice for an hour. After
incubation the cells were sonicated using Sonicator-Cell disruptor
Model W-225R (Heat systems-Ultrasonics, Inc. currently known as
Misonix, Inc, NY). The sonicator settings were as follows:
Stirrer speed: 1.5rpm
Output control on ‘5’
Time the solution was sonicated for: 1min
Interval between the sonications was for: 45secs
% Duty cycle: 42%
Under these conditions the frequency dial is at 30

While sonicating the cells the height of the stand on which the beaker was placed
was adjusted accordingly. The cells for sonication were kept in a test tube in the
beaker containing ice. Also sufficient care was taken so that the probe was
immersed in the cell solution but didn’t touch the walls or the bottom of the
tube.
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After sonicating the cells 1.382µL (i.e.19.36 u) of Rnase A (QIAGEN, CA) was
added from a 14u/µL solution to make up a 4u/µL solution. Then 38.72µL of
2u/µL DnaseI solution was added to the lysed cells containing Rnase A to make
a 16u/µL DnaseI containing solution. This mixture was stirred at 4°C for an
hour at a stirrer speed of 4rpm. This mixture was then centrifuged in Sorvall RC5B Refrigerated Super speed centrifuge (Dupont Instruments, DE) in an SS-34
rotor at 13.5K for twenty minutes.
The centrifuged mixture was removed and the cell extract was carefully decanted
into another clean sterile 20mL scintillation vial. 50µL of this extract was used for
spectral analysis. The spectral analysis revealed the presence of an enzyme with a
peak at 414 nm (as seen in Figure 31). It was confirmed from Figure 31 that a
heme protein was present. To observe the peaks accurately (as seen in Figure 32)
the enzyme was further purified using ultra filtration with a 30000 molecular
weight membrane.
3.7 Spectral analysis of P450cam after Carbon monoxide binding.
In order to prove the presence of the P450cam enzyme in the cell extract the first
and the most important assay is the carbon monoxide binding assay. This assay
has another special requirement, that the enzyme solution be reduced with
dithionite anaerobically. Dithionite gets quickly oxidized on exposure to air. Also
the dissolved oxygen in water can oxidize the dithionite when the required 1mM
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Figure 31: Absorbance spectra of the oxidized P450cam

Figure 32: Absorbance spectra of the concentrated P450cam
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solution is prepared. Therefore it is essential to keep the dithionite oxygen-free in
all forms and add it to an oxygen-free enzyme solution for the assay to be
successful. If the enzyme solution is not oxygen free it oxidizes the dithionite and
produces acid and other oxidation products that denature the enzyme.
Anaerobic conditions were established in the laboratory by purging the enzyme
with nitrogen. After a number of trials it was found that this was not sufficient to
provide the requisite condition, therefore another method was devised for better
results. A vial of water was crimp-capped, the headspace was vacuumed and was
purged with nitrogen alternately, and this vacuum-gas method was repeated thrice
to deaerate the headspace above the water level in the vial. The dissolved oxygen
in the water was then removed by repeating the same procedure. Thus the water
was deaerated. This water was used for the purpose of preparing deaerated
dithionite solution.
The enzyme solution was placed in a cuvette with a rubber stopper, it was made
oxygen-free by using the vacuum-gas method (gas used for purging was
nitrogen). The anaerobic dithionite solution was then carefully added to the
oxygen free enzyme solution in a ratio of 5:1(dithionite: enzyme). The spectrum
was then measured immediately to check if the enzyme was reduced. There was a
shift in the Soret band from 414nm to 411nm (shown in Figure 33) as expected.
Carbon monoxide gas was bubbled through the solution for five minutes using a
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Figure 33: Absorption spectra on adding dithionite (shift from 414nm to 411nm)
needle to maintain the anaerobicity; addition of carbon monoxide didn’t show the
expected shift in the Soret band from 411nm to 446nm.
3. 8 Assay using the camphor bound cytochrome P450cam
The cytochrome P450cam isolated was not in the camphor bound form. To
cytochrome P450cam at pH 7.4 (pH was adjusted by adding 50Mm Tris HCl
buffer) KCl and camphor were added such that the final enzyme solution had
0.1M KCl and 5mM camphor. The absorption spectrum of this solution was
measured from 200nm to 700nm. The absorption spectrum was expected to shift
from 414nm to 392nm; instead the shift was from 414nm to 405nm (as seen in
Figure 34).
Then dithionite was added anaerobically as before to the camphor bound enzyme
and the spectrum were measured but it didn’t show the expected shift of the

72

Figure 34: Absorption spectra of the Oxidized P450cam containing 5mM camphor
Soret band to 409nm (Figure 35). Neither did bubbling carbon monoxide
through the dithionite reduced solution shift the peak to 446nm (Figure 36).

3.9 Control experiment
Escherichia coli (DH5α) cells containing pKSD6-1 were grown in LB containing
50µg/mL ampicillin and 30µg/mL chloramphenicol at 37°C overnight. These
cells showed no growth. Upon verification it was found that these Escherichia coli

73

Figure 35: Absorbance spectra of oxidized P450cam and camphor with dithionite

Figure 36: Absorbance spectra of P450cam+ Camphor+ Dithionite +Carbon
monoxide
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cells containing the pKSD6-1 plasmid had always been grown only in 50µg/mL
ampicillin. Therefore the control cells were grown in LB containing only.
50µg/mL ampicillin whereas the recombinant cell culture (Escherichia coli
containing pKSD6-1 +P450) was grown in LB (Luria Broth) containing
50µg/mL ampicillin and 30µg/mL chloramphenicol and the protein was
expressed in each culture according to the same protocol as before. An
absorption spectrum was taken for the protein extract from each cell culture
(Figure 37), which proves that only the recombinant pKSD6-1+CYP101 cells
produce a peak at 420nm.
As seen from Figure 37 it is evident that the control doesn’t produce the
cytochrome P450cam enzyme and therefore the recombinant pKSD6-1+CYP101
DNA contain the cloned P450cam gene. To make it certain that the control
doesn’t produce any peak at all, the protein extract from the cell culture was
concentrated to thrice its original concentration and its absorption spectra was
again measured (shown in Figure 38).

3.10 Analysis of Recombinant DNA.
It was also necessary to prove the presence of the cytochrome P450cam gene in the
recombinant plasmid using molecular biology tools like restriction and gel
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Figure 37: Absorption spectra of the protein extract control and recombinant
culture

Figure 38: Difference in spectra of control (concentrated) and recombinant
protein extract
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analysis. Isolation of the recombinant pKSD6-1 containing P450cam was a difficult
task. The DNA couldn’t be isolated using the standard boiling prep protocol.
After many trials the recombinant DNA was isolated .The uncut band was run on
the gel and its size was observed to be 20kbp (seen in Figure 39). When this
recombinant DNA was restricted with NotI, ApaI and BspEI, NotI +BspeI,
NotI+ApaI the solutions were analyzed on an agarose gel (shown in Figure 40),
they showed no DNA at all. Repetitive attempts produced similar results. This led
to the conclusion that the DNA might have been degraded by Dnase activity.
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Figure 39: Agarose gel showing the
uncut recombinant pKSD6-1+P450 at
20kbp.
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Figure 40: Restriction digests of
recombinant pKSD6-1+P450 with
various enzymes.
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Chapter 4

ANALYSIS AND DISCUSSION

4.1 Recombinant Protein Expression in Escherichia coli
The Gram-negative bacterium Escherichia coli is the most widely- used organism
for producing heterologous proteins because of its ability to grow rapidly and at
high density on inexpensive substrates, its well-characterized genetics and the
availability of a large number of cloning vectors. The unique and subtle structural
features of the gene sequence, the stability and the translational efficiency of the
mRNA, the ease of protein folding, degradation of the protein by host cell
proteases, major differences in codon usage between the foreign gene and native
Escherichia coli and potential toxicity of the protein to the host Escherichia coli are
some of the probable reasons why a gene might not be efficiently expressed in
Escherichia coli. [37, 38]
Several elements need to be considered for efficient expression of genes and the
highest level of protein synthesis. Figure 41 below shows the essential
architecture of an Escherichia coli expression vector. The promoters in Escherichia
coli are 10-100bp upstream of the ribosome-binding site (RBS) and the promoter
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Figure 41: Schematic presentation of
the salient features and sequence
elements of a prokaryotic expression
vector. [38]
is under the control of a regulatory gene (R), which may be present either on the
vector or on the host chromosome. The promoters of Escherichia coli consist of a
hexanucleotide sequence that is about 35bp upstream of the transcription
initiation base (-35 region), separated by a spacer region from another
hexanucleotide sequence (-10 region). [38]
The RBS (ribosome binding site), which spans approximately 54 nucleotides
bound by positions –35 (±2) and +19 and +22 of the mRNA coding sequence is
located downstream of the promoter. The Shine-Dalgarno (SD) site interacts
with the 3′ end of the 16SrRNA during translation initiation. The range of the
distance between the SD site and the initiation codon should be 5-13bp. The
transcription terminator is located downstream of the coding sequence and serves
as a signal to terminate
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transcription. Vectors also contain a gene that confers resistance on the host to
aid in plasmid selection and propagation. [38]

4.2 Requirements for expression of cytochrome P450cam in Escherichia coli
The active enzyme cytochrome P450cam requires the proper coordination of the
non-covalently bound heme, which must be produced and incorporated into the
nascent polypeptide.
For successful synthesis of cytochromeP450cam in Escherichia coli

•

The gene encoding the particular P450 should be cloned downstream of
an efficient promoter and the ribosome-binding site should be present on
a multicopy number plasmid.

•

An efficient promoter should direct the synthesis of hybrid mRNA
molecules that contain signals immediately upstream of the initiation
codon that directs Escherichia coli ribosomes to initiate translation of the
inserted gene sequence.

•

On being translated the nascent polypeptides should bind a molecule of
heme and fold into the final tertiary structure.
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•

Production of the recombinant protein in Escherichia coli places additional
burden on the cellular metabolism in Escherichia coli and therefore it is
necessary for the cell to produce the proteins (Gro ES and Gro EL)
required for folding. [39]

4.3 Synthesis of cytochrome P450cam enzyme in Escherichia coli using the
vector pKSD6-1
Cytochrome P450cam gene was cloned at the ApaI site in the multiple cloning site
of the shuttle vector pKSD6-1. The MCS (multiple cloning site) of pKSD6-1 has
been derived from the pBluescript II KS (-) plasmid. [18] Since the entire
sequence of the pKSD6-1 is not known (not given in [18]) the sequence of the
gene-containing fragment of recombinant pKSD6-1+CYP101 was constructed
using some of the information that is given in [18]. First, the 3-TOPO+CYP101
sequence was constructed using pCR2.1 TOPO and the CYP101 sequence (the
gene had appropriate primer ends). From this sequence the ApaI-ApaI fragment
containing the cytochrome P450cam gene was taken and was added at the ApaI
site in the MCS of pBluescript II KS (-)(Statagene). The various factors such as
the promoter, the Shine-Dalgarno sequence etc that affect the expression of the
protein in Escherichia coli were analyzed with the above sequence.
When the 5′ApaI-ApaI 3′ was inserted into the ApaI in the MCS of the shuttle
vector, the cytochrome P450 gene was found to be expressed under the T7
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promoter. Some of the essential features for expression of the protein were found
to be missing in the sequence. Though the -10 consensus sequence (TATA) was
present, the -35 consensus sequence (TTGACA) was not as it should be, the very
important Shine-Dalgarno sequence was not present between the promoter and
gene and finally when this sequence was checked for ORFs (Open reading
frames) using NEB cutter the protein being translated by the gene was
451aa(amino acid residues) instead of 414aa and the protein start codon was
TTG(present on the vector) instead of ATG (present on the plasmid). These
factors led to the conclusion that the gene might have been ligated in the reverse
direction.
The inverse sequence of the 5′ApaI-ApaI 3′ was obtained from [40] and inserted
into the ApaI site of the shuttle vector (sequence given as Figure 42). This
ligation puts the gene under the control of the T3 promoter. The sequences when
analyzed using the NEB cutter showed the production of 415aa with an ATG
start codon. The way in which the sequence was ligated causes the 3′-5′ strand to
be the coding gene (Figure 43). The distance between the start codon ATG and
the T3 promoter was found to be only 26 nucleotides. The -10 sequence and -35
sequence for the lac promoter in Escherichia coli are 5′TATGTT 3′ and 5′TTTACA
3′ since the gene was ligated in the inverse direction the-10 and the -35 regions
found on the 5′-3′ of the gene are 5′ AACATA 3′ and 5′ TGTAAA 3′; these are
situated 69bp (base pairs) and 93bp upstream of the promoter on the coding gene
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CTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTAC
ACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTC
CCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCA
AAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTG
ACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCG
GTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAAC
AAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCTGCGCAAC
TGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTG
CAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAG
CGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAG
TGGATCCCCCGGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGAGGGGGGGCCCT
CTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCGCCCTTCATGAGCTCAAG
CTTTGGATAGCGGTGGTAGGTGATGGGGAATTACCGTCGCATCCCCCACCAACCGGATATTGCCTTCC
CAGCCGCTGGCGCGCAGGCCGAAGGCGACCTCAACGCCAGCCAGTCCGGTACCGACGATGACCACGTT
GTCGTTTGCGTTCACTTAGCACGCACTCCCATGTGTTTATACCGCTTTGGTAGTCGCCGGATCCCAGAC
CAGAGGGAGTGCCTGCACGCCGCTGACGATGCCGCTCTTGTGCTGAATCTGGGCACCCGGGGCAATG
GAGAAGTCAGGAATCCTGGTCAGCCATTCCTTGAGGGTGACGATGATTTCCCGGCGGGCCAGGTGCT
GGCCAAGGCACAGATGGCTGCCGTGGCCAAAGGTGGTGTGTGAAACCTTTTGGCGACTGAAGTCGAC
GTGCATCGGGCAGGCGTTTTCGCGCTCATCCAGGCCAGACAGCATCTGCGGTAGCAGGATCTGGTCAC
CTTTCTTCAGTTGCACGCCATGAAACTCGTAATCGGAGGTGAGGATGCGGCCATCGGCAACCAGCGAG
AAGCGCCGGAGTAGTTCCTCGCAAGCGGCTGGAATACGCTCGGGACGCTCGATCAGCTCCTGGCGAT
GCTCCGGGCTTTTGGCCAGGAACTCCATGCTGAAGCTGAGGAAATTGACCACCGTATCCAGGCCGCCG
ACCAGTAACAGGCCACACATCCTCTTGGCTTCGTCACTGGTGATCGGTCGCCCATTGACCTGGCCGTTG
GCAACGATGCTGATAGCGTCGGTTCCCGGCTTCTGCCTGCGTTGCTCGATGATCGGTATCAGATAGTC
GTAGAGCGCCTCCTTGGCCTCTGCGAAGGTCATGCTGCCATCCGGACGGGTCATCTGATCCGTTAGGT
ATTTCAAGTGCGGGATATCTTCTTCCGGTAGACCTGCGAGCAGCATGAAGATGCGTATCGGGAAGGGT
TCGGCGTAGTCCTCGGTGAAGTTGCACTGTCCTTGCGGGCGCAGGCTCTCGATCAGCGAGCAGGCCA
GCTCCTGGATCCGGTTCTCCAGCTTATCCACCACCGGCATGCCAACCACTTGGTTGGCCAGCGCACGAA
ACTGGCGCTGCTCGGGCGGATCCATCGAGGTGGGAATGAAGTCGTAGGCTTCGCCGGCTTCACGAGG
GATGAACGGGCACTCGCTGGAAAAGTGGCGGTAATCTTCATAGGCCTCACGGATCAGTTGGCCGCGA
GTGGCGATCCAGTGTCCGCCGTTGCAGCGAGTCCACACCAGATCCGGTACGTTTGATTCTTGCAGAAC
TGCCCAGGCCTCCTGCACGCCGGCAGACAGATTCGACGGATTGTACATGTCGAAGTCGAATACCAGGT
GCTCTGGCACATGGGGTGGCAGAGGGGCAAGATTGGCGTTGCTTTGTATGGTTTCAGTCGTCATTGT
GGGCCCGGTACCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCAT
AGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGT
GTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCC
AGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCG
TATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGG
TATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATG
TGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCT
CCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTAT
AAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCG
GATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCA
GTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCC
ACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTA
ACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCA
GTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCT
TTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAA
TGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCG
TCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGAC
CCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGG
TCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCC
AGTTAATAGTTTGCGCAACGT

CCCTTTAGTGAGGGTTAATT-T3 Promoter ,GGGCCC-ApaI site,TTA
AACATA -10 SITE,CAT N-terminal TGTAAA -35 SITE

C-terminal,

Figure 42: Sequence of a part of pKSD6-1 containing the CYP101 gene in its
MCS
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Figure 43: The direction of translation
of the protein

respectively. The Shine-Dalgarno (SD) sequence for the lac I is 5′ GGUGGU 3′
which should be found on the sequence in Figure 42 as 5′ ACCACC5′ -3′ between
the promoter and the coding gene, but such a sequence was not present. This
suggests that there might be another possible SD sequence as they vary from one
promoter to another. When the sequence given in Figure 42 was analyzed in
NEB cutter for ORFs, the sequence encoding the cloned gene was found to
produce a protein of 415 aa (Figure 44). From the above analysis it is clear that
the enzyme being produced is a P450.
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MTTETIQSNA
EAWAVLQESN
VPDLVWTRCN
REAGEAYDFI
PTSMDPPEQR
ESLRPQGQCN
FTEDYAEPFP
SMTFAEAKEA
LYDYLIPIIE
RMCGLLLVGG
LDTVVNFLSF
RRFSLVADGR
ILTSDYEFHG
FSRQKVSHTT
FGHGSHLCLG
QHKSGIVSGV
QALPLVWDPA

NLAPLPPHVP EHLVFDFDMY NPSNLSAGVQ
GGHWIATRGQ LIREAYEDYR HFSSECPFIP
QFRALANQVV GMPVVDKLEN RIQELACSLI
IRIFMLLAGL PEEDIPHLKY LTDQMTRPDG
QRRQKPGTDA ISIVANGQVN GRPITSDEAK
SMEFLAKSPE HRQELIERPE RIPAACEELL
VQLKKGDQIL LPQMLSGLDE RENACPMHVD
QHLARREIIV TLKEWLTRIP DFSIAPGAQI
TTKAV

Figure 44: 415 aa sequence encoded
by the gene.

4.4 The chloramphenicol resistance gene
The multitude of attempts made at cloning the cytochrome P450cam gene from 3TOPO+CYP101 into pKSD6-1 were met with consistent failures. It was always
presumed that there was something wrong with the vector: insert ratio and lots of
attempts were made in trying to improve the quantities and the ratios of the
vector and insert used whereas in fact the problem might have actually been with
the expression of the resistance genes in the vector.
While performing the control experiment it was observed that the Escherichia coli
(DH5α) cells containing the shuttle vector pKSD6-1 (without the CYP101 gene)
was unable to grow in a LB containing both chloramphenicol and ampicillin,
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though it has both the resistance genes as seen in Figure 16.But the same cells
were capable of growing in LB containing only ampicillin.
The Escherichia coli (DH5α) cells containing only pKSD6-1 were cultured
previously to isolate vector DNA. This vector DNA was used in constructing the
recombinant plasmid of pKSD6-1 containing P450cam. The cells of the single
positive clone isolated after transforming the recombinant plasmid initially took
about 48hrs to grow in media containing both antibiotics.
Requirements of some gene products change over time. The need for enzymes in
certain metabolic pathways wax and wane as the food sources change or are
depleted. From the above observations, it is possible that the chloramphenicol
resistance gene was lost due to a possible mutation. It was cultured only in media
with ampicillin in the lab for over a year and it could have been lost due to a lack
of selective pressure over generations. This could be one of the main reasons why
the clones didn’t grow on agar plates containing ampicillin and chloramphenicol.

4.5 Spectral Analysis of the P450cam enzyme from the recombinant plasmid.
The oxidized enzyme in the camphor-free form has two absorption maxima; one
at 414nm and the other at 550nm instead of the expected maxima at 418 and
535nm, the other expected peaks at 280nm and 570nm were not observed. Also
the absorption maxima did shift from 414nm to 411nm when reduced with
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dithionite (Na2S2O4) and gassed with carbon monoxide. Camphor binding assay
showed absorption maxima shift to 405nm instead of the expected 392nm, but
the other shifts were not observed.
Theoretically the absorption spectra of the oxidized camphor-free form of the
cytochrome P450cam enzyme has α andβ bands at 571nm and 538nm, the Soret
band is 417nm, a γ band at 365nm and aromatic acid content is seen at 280nm
with a shoulder at 290nm, in the experiments only the Soret band was observed
at 414nm and instead of the two α and β bands a single peak was observed at
550nm.
The presence of the Soret band at 414nm confirms the presence of the heme
protein, cytochrome P450cam. Actually both α and β bands fuse into a single band
at 550nm because of the formation of a complex between the reduced
cytochrome P450cam and carbon monoxide. The single band formed at 550nm in
the experiments. The other bands like γ band at 365nm and others could not be
observed because the sample was not very pure. Addition of camphor to the
enzyme solution shifts the Soret band to 405nm instead of 392nm.Whereas
reduction with dithionite and later addition of carbon monoxide didn’t show the
expected bands.
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4.6 Possibility of the enzyme being cytochrome P420
Cytochrome P420 is an inactive form of cytochrome P450 that can be formed
from all types of known P450s by incubation with acetone or exposure to high
temperature and pressure. The P420 has a Soret absorption band at 420nm and
the α and β bands coalesce into a single band in the α band region (at571nm), on
adding sodium dithionite the Soret band shifts to 423nm and the α band is
at556nm. Soret absorption of the ferrous-CO complex is more intense with a
420nm maximum. Addition of a substrate or inhibitor doesn’t alter the P420
absorption bands. P420 is a collective term as some forms can be converted back
into the active enzyme and show the ferrous-CO spectrum of the native protein
while others cannot. Also the spectra of the P420 samples can vary in the Soret
and α regions. [41]
The Soret band at 414nm, the coalescence of the α and β bands in a single band
at 550nm observed in the results suggest the presence of P420, the inactive form
P450cam in the enzyme solution. But there is no shift in the Soret or the α band
on reducing the enzyme with dithionite; this could be because the reduction was
not done under appropriate (anaerobic) conditions. Again addition of camphor to
the enzyme solution shouldn’t produce a shift in the absorption bands if the
enzyme were P420, but the enzyme solution did show a shift in its Soret band
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from 414nm to 405nm on addition of camphor, so the enzyme may not be a
P420.

4.7 Other Possible reasons for the lack of enzymatic activity
Lack of proper thiolate coordination: The heterolytic oxygen scission of the heme
bound oxygen is supposed to be facilitated by the strong electron donation of the
anionic thiolate axial heme ligand. The inactivated form P420 lacks such thiolate
coordination. Any mutation at the Cys357 residue is bound to destroy the heme
environmental structure resulting in the loss of enzymatic activity.
Errors in the PCR: While producing the CYP101 gene from PCR using the
pCWori+CYP101 as template there is a possibility that there were some
mutations because of the limited fidelity of the Taq polymerase enzyme. If there
were any such errors these have not been investigated in any way. Even a single
mutation in the gene can alter the amino acid residues produced, hence the
protein and thereby its spectral characteristics.
The enzyme is being produced in an inactive form, the causes for the lack of
activity in the enzyme may be because of some deleterious mutation in the gene
encoding for the enzyme. Also the disappearance of chloramphenicol resistance
activity from the shuttle vector played an important role, in the sense better
clones could have been isolated if this problem was observed earlier.
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Chapter 5

SUMMARY AND FUTURE WORK

5.1 Summary
The fundamental idea of the project was to clone the CYP101 gene into the
Rhodococcus-Escherichia coli shuttle vector pKSD6-1, so that the enzyme can be
expressed in Rhodococcus and it can be tailored using random mutagenesis to act on
the carcinogenic PAHs, which are not readily degraded by naturally occurring
enzymes or on the alkanes for producing commercially useful alcohols.
The cytochrome P450cam (CYP101) gene was produced with appropriate ends
using pCWori +CYP101 as a template for polymerase chain reaction (PCR), and
employing suitable primers that were designed using sites ApaI and SacI for the
forward and the backward primers respectively. Direct cloning of the PCR
product into the shuttle vector pKSD6-1 was not possible, because SacI site was
found to have three restriction sites on the shuttle vector pKSD6-1. It was
therefore necessary to find an alternative way to clone the CYP101 gene into the
shuttle vector pKSD6-1.
The pCR 2.1 TOPO is a commercially available vector with ‘T’ endings into
which the cytochrome P450cam gene that was produced from the PCR with
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P4501F and P4501R primers was cloned. This recombinant plasmid of
TOPO+CYP101 was transformed into Escherichia coli. The positive clones were
restricted with NotI enzyme to test for the presence of the CYP101 gene. The
presence of a 5.4 kbp product from the colony 3 during gel analysis confirmed
the presence of the gene
ApaI site was found to be the only restriction site that was compatible for cloning
the cytochrome P450cam gene from 3-TOPO+CYP101 to pKSD6-1. The gene
was restricted with ApaI enzyme from 3-TOPO+CYP101 and was cloned into
pKSD6-1 that was also restricted with ApaI and the recombinant pKSD61+CYP101 plasmid was transformed into Escherichia coli (DH5α). Only one
positive clone was found, which was grown in suitable medium containing the
suitable antibiotics, chloramphenicol and ampicillin and stored.
The cytochrome P450cam enzyme was expressed from the aforementioned
positive clone containing the P450cam gene in pKSD6-1. Spectral analysis of the
protein extract revealed an enzyme showing a peak at 414nm instead of the
expected 417nm and one at 550nm. Carbon monoxide binding assay did not
show the expected shift in the peaks. The camphor-bound enzyme showed a shift
in the Soret band from 414nm to 405nm instead of the expected 392nnm.
The results from the camphor and the carbon monoxide binding assays suggest
that the enzyme present may be the inactive form of the cytochrome P450cam
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enzyme; cytochrome P420 or the cytochrome P450cam enzyme with some
mutation. The DNA analysis of the recombinant pKSD6-1+CYP101 plasmid
was unsuccessful. Difficulties in the isolation of the recombinant DNA and
degradation of the DNA during restriction analysis have caused speculation that
the degradation might be a result of Dnase action.

5.2 Future work
The work presented in this thesis is just a step towards achieving the final goal of
expressing cytochromeP450cam gene in a Rhodoccocus-Escherichia coli shuttle vector
and tailoring the enzyme to act on the hydrocarbons of environmental and
industrial interest. The first step towards achieving this end would be to generate
a better clone than the available one.
In order to generate a better clone, it is essential to know more about the existing
one. Therefore sequencing the present clone would provide a lot of information.
From the sequence it could be found out if the gene was inserted properly and
whether there are any mutations in the gene. If there are no mutations present in
the gene then experiments should be carried out to investigate why the enzyme is
not exhibiting its characteristic spectral properties.
Also the sequence of the clone will give information about the chloramphenicol
resistance gene. Whether or not another attempt should be made at cloning the
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cytochrome P450cam gene into pKSD6-1 will depend on the results of the
aforementioned analysis of the existing clone. Then the better clone can be
transformed into Rhodococcus cells through electroporation, the protein should be
expressed and enzyme assays should be performed to test the presence of the
cytochrome P450cam. If the enzyme is present then it can be tested on
polyaromatic hydrocarbons and alkanes for its activity and later engineered to suit
the particular process.
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